Advertisement
<< Back To Article
No Link Between Hep C Treatment With DAAs and Liver Cancer Risk

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

Susan

Latest research states, “The collective findings did not support the notion that DAAs promote hepatocarcinogensis, researchers concluded.” However, “Maan and Feld concurred with that conclusion, adding that since achieving SVR does not eliminate risk of the development of HCC in those with cirrhosis, "early treatment to prevent cirrhosis is the preferred strategy.”

January 30, 2019


Hot topics


Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.